Furthermore, Ossenkoppele et al. [121] investigated tau PET status across a broad cohort, identifying a high tau PET positivity in AD dementia and MCI with Aβ+ status, notably lower in non-AD and CU groups. The gene discussed is MAPT; the disease is Alzheimer disease.